Status as Stockholder. Upon each Conversion Date, (i) the shares of Series B Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series B Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B Preferred Stock.
Appears in 3 contracts
Samples: Securities Exchange Agreement (Oncothyreon Inc.), Loan and Security Agreement (Cytokinetics Inc), Underwriting Agreement (Oncothyreon Inc.)
Status as Stockholder. Upon each Conversion Date, (i) the shares of Series B A Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series B A Preferred Stock shall cease and terminate, excepting only the right to receive certificates for or electronic receipt of such shares of Common Stock Stock, as applicable, and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder Holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B A Preferred Stock.
Appears in 2 contracts
Samples: 3(a)(9) Exchange Agreement (Cullinan Oncology, Inc.), 3(a)(9) Exchange Agreement (Verastem, Inc.)
Status as Stockholder. Upon each Conversion Date, (i) the shares of Series B Y Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series B Y Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder Holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B Y Preferred Stock.
Appears in 2 contracts
Samples: Investment Agreement (Biotechnology Value Fund L P), Investment Agreement (XOMA Corp)
Status as Stockholder. Upon each Conversion Date, (i) the shares of Series B D Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series B D Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B D Preferred Stock.
Appears in 2 contracts
Samples: Securities Purchase Agreement (InspireMD, Inc.), Placement Agent Agreement (Cascadian Therapeutics, Inc.)
Status as Stockholder. Upon each Conversion Date, (i) the shares of Series B X Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series B X Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder Holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B X Preferred Stock.
Appears in 2 contracts
Samples: Investment Agreement (Cti Biopharma Corp), 3(a)(9) Exchange Agreement (Cidara Therapeutics, Inc.)
Status as Stockholder. Upon each Conversion Date, (i) the shares of Series B Z Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series B Z Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder Holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B Z Preferred Stock.
Appears in 1 contract
Samples: Investment Agreement (XOMA Corp)
Status as Stockholder. Upon each Conversion Date, : (i) the shares of Series B A Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series B A Preferred Stock shall cease and terminate, excepting only the right to receive certificates for or (if applicable and permitted under the Securities Act) electronic delivery of such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder Holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B A Preferred Stock.
Appears in 1 contract
Samples: Contribution Agreement (HedgePath Pharmaceuticals, Inc.)
Status as Stockholder. Upon each the Conversion Date, : (i) the shares of Series B A Preferred Stock being converted shall be deemed converted into shares of Common Stock Stock; and (ii) the Holder’s Holders’ rights as a holder holders of such converted shares of Series B A Preferred Stock shall cease and terminate, excepting only the right to receive certificates book entry notations for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder Holders because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder Holders shall retain all of its rights and remedies for the Corporation’s failure to convert Series B A Preferred Stock.
Appears in 1 contract
Samples: Convertible Series a Preferred Stock Purchase Agreement (FREYR Battery, Inc. /DE/)
Status as Stockholder. Upon each Conversion Date, (i) the shares of Series B E Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series B E Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder Holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B E Preferred Stock.
Appears in 1 contract
Samples: 3(a)(9) Exchange Agreement (Pieris Pharmaceuticals, Inc.)
Status as Stockholder. Upon each Conversion Date, (i) the shares of Series B D Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series B D Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder Holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B D Preferred Stock.
Appears in 1 contract
Samples: 3(a)(9) Exchange Agreement (Pieris Pharmaceuticals, Inc.)
Status as Stockholder. Upon each Conversion Date, (i) the shares of Series B E Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series B E Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B E Preferred Stock.
Appears in 1 contract
Samples: Underwriting Agreement (Cascadian Therapeutics, Inc.)
Status as Stockholder. Upon each Conversion Date, (i) the shares of Series B C Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series B C Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B C Preferred Stock.
Appears in 1 contract
Status as Stockholder. Upon each Conversion Date, (i) the shares of Series B C Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Series C Holder’s rights as a holder of such converted shares of Series B C Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock Stock, the right to rescind such conversion as set forth in Section 6 above, and to any remedies provided herein or otherwise available at law or in equity to such Series C Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designationherein. In all cases, the holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B C Preferred Stock.
Appears in 1 contract
Samples: Securities Exchange Agreement (Unique Logistics International Inc)
Status as Stockholder. Upon each Conversion Date, (i) the shares of Series B C Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series B C Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B C Preferred Stock.
Appears in 1 contract
Samples: 3(a)(9) Exchange Agreement (Bain Capital Life Sciences Fund, L.P.)
Status as Stockholder. Upon each Conversion Date, (i) the shares of Series B Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series B Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder Holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B Preferred Stock.
Appears in 1 contract
Samples: 3(a)(9) Exchange Agreement (Pieris Pharmaceuticals, Inc.)
Status as Stockholder. Upon each Conversion Date, : (i) the shares of Series B A Preferred Stock being converted shall be deemed converted into shares of Common Stock Stock; and (ii) the Holder’s rights as a holder of such converted shares of Series B A Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B A Preferred Stock.
Appears in 1 contract
Status as Stockholder. Upon each Conversion Date, (i) the shares of Series B A Preferred Stock being converted shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a holder of such converted shares of Series B A Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B A Preferred Stock.
Appears in 1 contract
Status as Stockholder. Upon each Conversion Date, : (i) the shares of Series B C Preferred Stock being converted shall be deemed converted into shares of Common Stock Stock; and (ii) the Holder’s rights as a holder of such converted shares of Series B C Preferred Stock shall cease and terminate, excepting only the right to receive certificates (or book entry notations) for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B C Preferred Stock.
Appears in 1 contract
Samples: Securities Purchase Agreement (T2 Biosystems, Inc.)
Status as Stockholder. Upon each Conversion Date, : (i) the shares of Series B D Preferred Stock being converted shall be deemed converted into shares of Common Stock Stock; and (ii) the Holder’s rights as a holder of such converted shares of Series B D Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B D Preferred Stock.
Appears in 1 contract
Status as Stockholder. Upon each Conversion Date, : (i) the shares of Series B C Preferred Stock being converted shall be deemed converted into shares of Common Stock Stock; and (ii) the Holder’s rights as a holder of such converted shares of Series B C Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B C Preferred Stock.
Appears in 1 contract
Status as Stockholder. Upon each Conversion Date, : (i) the shares of Series B C-1 Preferred Stock being converted shall be deemed converted into shares of Common Stock Stock; and (ii) the Holder’s rights as a holder of such converted shares of Series B C-1 Preferred Stock shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation. In all cases, the holder shall retain all of its rights and remedies for the Corporation’s failure to convert Series B C-1 Preferred Stock.
Appears in 1 contract